Skip to content

Concurrent tDCS for Chronic Pain in Adults With Cerebral Palsy

Not yet recruitingNot applicableNCT07846436
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to find out whether combining transcranial direct current stimulation (tDCS) using the Starstim tES8 device with motor-based activities, such as action observation or motor imagery (chosen based on task-fMRI results showing activation in the primary motor cortex), is a feasible treatment for chronic pain.

Study details

Official title
Concurrent Transcranial Direct Current Stimulation and Motor Tasks for Chronic Pain in Adults With Cerebral Palsy: A Feasibility Pilot Study
Conditions
Interventions
  • Device: Trans Cranial Direct Current Stimulation
Sponsor
Gillette Children's Specialty Healthcare
Start date
2026-10
Primary completion
2028-10
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Total sites listed
0

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18 years or older * Diagnosis of Cerebral Palsy * Chronic pain associated with movement * Own legal decision maker * Current level of at least moderate pain (\>=4 out of 10, as assessed by the average pain Eligibility text messages) * Eligible for MRI without sedation * Has a cellular device that can receive and respond to study text messages * Has stable doses of prescription medications for at least 1 month prior to study participation and no anticipated change in medication plan during the participation. Exclusion Criteria: * Non-English speaking * Non-verbal * Implanted medical devices * Any metal in the head * Has had unexplained episodes of loss of consciousness * Diagnosis of epilepsy or history of seizures * Diagnosis of bipolar disorder, schizophrenia, or autism spectrum disorder * Damage of skin at sites of stimulation * Currently suffering from severe or frequent headaches * Has had a traumatic brain injury * Any serious life-threatening disease such as congestive heart failure, pulmonary obstructive chronic disease or active neoplasia * Pregnant * Have previously used tDCS or TMS and had an adverse reaction * Diagnosis of severe substance or alcohol use disorder within 3 months of enrollment

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07846436